As of 2026-04-07, the Relative Valuation of Corcept Therapeutics Inc (CORT) is 11.81 USD. This relative valuation is based on P/E multiples. With the latest stock price at 40.85 USD, the upside of Corcept Therapeutics Inc based on Relative Valuation is -71.1%.
The range of the Relative Valuation is 7.25 - 17.28 USD.
| Range | Selected | |
| Trailing P/E multiples | 12.7x - 18.4x | 15.2x |
| Forward P/E multiples | 12.5x - 19.1x | 16.2x |
| Fair Price | 7.25 - 17.28 | 11.81 |
| Upside | -82.2% - -57.7% | -71.1% |
| Date | P/E |
| 2026-04-02 | 45.35 |
| 2026-04-01 | 44.81 |
| 2026-03-31 | 43.03 |
| 2026-03-30 | 40.69 |
| 2026-03-27 | 40.13 |
| 2026-03-26 | 41.13 |
| 2026-03-25 | 43.20 |
| 2026-03-24 | 36.10 |
| 2026-03-23 | 35.90 |
| 2026-03-20 | 36.98 |
| 2026-03-19 | 36.38 |
| 2026-03-18 | 35.54 |
| 2026-03-17 | 35.77 |
| 2026-03-16 | 34.35 |
| 2026-03-13 | 34.32 |
| 2026-03-12 | 34.57 |
| 2026-03-11 | 36.01 |
| 2026-03-10 | 35.80 |
| 2026-03-09 | 36.28 |
| 2026-03-06 | 36.15 |
| 2026-03-05 | 36.33 |
| 2026-03-04 | 38.10 |
| 2026-03-03 | 37.66 |
| 2026-03-02 | 38.39 |
| 2026-02-27 | 38.11 |
| 2026-02-26 | 38.19 |
| 2026-02-25 | 38.66 |
| 2026-02-24 | 38.94 |
| 2026-02-23 | 37.72 |
| 2026-02-20 | 37.17 |
| 2026-02-19 | 36.55 |
| 2026-02-18 | 42.50 |
| 2026-02-17 | 42.30 |
| 2026-02-13 | 42.66 |
| 2026-02-12 | 40.92 |
| 2026-02-11 | 43.58 |
| 2026-02-10 | 43.73 |
| 2026-02-09 | 44.09 |
| 2026-02-06 | 43.58 |
| 2026-02-05 | 40.95 |
| 2026-02-04 | 42.84 |
| 2026-02-03 | 43.44 |
| 2026-02-02 | 43.45 |
| 2026-01-30 | 42.56 |
| 2026-01-29 | 47.62 |
| 2026-01-28 | 48.94 |
| 2026-01-27 | 49.34 |
| 2026-01-26 | 48.71 |
| 2026-01-23 | 46.94 |
| 2026-01-22 | 44.08 |